32 min
Caitlyn Krebs | Nalu Bio - Encore Cannabis Capital
-
- Investing
Learning from nature, delivering through chemistry.
The end of cannabis prohibition has made cannabis research possible which has generated a wave of cannabis biotech start-ups. Caitlyn Krebs the co-founder and CEO of Nalu Bio joins Ross O'Brien and Maggie Kelly from Bonaventure Equity to talk about the challenges and opportunities of being at the intersection of biotech and cannabis. As an entrepreneur with many successful exits under her belt she also shares advice for aspiring entrepreneurs.
Produced by PodConX
Cannabis Capital - https://podconx.com/podcasts/cannabis-capital
Ross O'Brien - https://podconx.com/guests/ross-obrien
Maggie Kelly - https://podconx.com/guests/maggie-kelly
Bonaventure Equity - https://www.bvequity.com/
Caitlyn Krebs - https://podconx.com/guests/caitlyn-krebs
Nalu Bio - https://www.nalubio.com/
Learning from nature, delivering through chemistry.
The end of cannabis prohibition has made cannabis research possible which has generated a wave of cannabis biotech start-ups. Caitlyn Krebs the co-founder and CEO of Nalu Bio joins Ross O'Brien and Maggie Kelly from Bonaventure Equity to talk about the challenges and opportunities of being at the intersection of biotech and cannabis. As an entrepreneur with many successful exits under her belt she also shares advice for aspiring entrepreneurs.
Produced by PodConX
Cannabis Capital - https://podconx.com/podcasts/cannabis-capital
Ross O'Brien - https://podconx.com/guests/ross-obrien
Maggie Kelly - https://podconx.com/guests/maggie-kelly
Bonaventure Equity - https://www.bvequity.com/
Caitlyn Krebs - https://podconx.com/guests/caitlyn-krebs
Nalu Bio - https://www.nalubio.com/
32 min